272 related articles for article (PubMed ID: 28122089)
21. MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy.
Biswas S; Thomas AA; Chen S; Aref-Eshghi E; Feng B; Gonder J; Sadikovic B; Chakrabarti S
Sci Rep; 2018 Apr; 8(1):6526. PubMed ID: 29695738
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
McArthur K; Feng B; Wu Y; Chen S; Chakrabarti S
Diabetes; 2011 Apr; 60(4):1314-23. PubMed ID: 21357793
[TBL] [Abstract][Full Text] [Related]
23. Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy.
Yuan Y; Zhu A; Zeng L; Wang X; Zhang Y; Long X; Wu J; Ye M; He J; Tan W
BMC Ophthalmol; 2024 Jun; 24(1):267. PubMed ID: 38907191
[TBL] [Abstract][Full Text] [Related]
24. LncRNA FENDRR promotes high-glucose-induced proliferation and angiogenesis of human retinal endothelial cells.
Shi Y; Chen C; Xu Y; Liu Y; Zhang H; Liu Y
Biosci Biotechnol Biochem; 2019 May; 83(5):869-875. PubMed ID: 30700211
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.
Yoshida S; Murata M; Noda K; Matsuda T; Saito M; Saito W; Kanda A; Ishida S
Jpn J Ophthalmol; 2018 Mar; 62(2):256-264. PubMed ID: 29392528
[TBL] [Abstract][Full Text] [Related]
26. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract][Full Text] [Related]
27. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina.
Wang Q; Bozack SN; Yan Y; Boulton ME; Grant MB; Busik JV
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3986-94. PubMed ID: 24867582
[TBL] [Abstract][Full Text] [Related]
28. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells.
Chen S; Chakrabarti R; Keats EC; Chen M; Chakrabarti S; Khan ZA
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8333-43. PubMed ID: 23150625
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
[TBL] [Abstract][Full Text] [Related]
30. Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.
Fan G; Gu Y; Zhang J; Xin Y; Shao J; Giampieri F; Battino M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847264
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA-antisense noncoding RNA in the INK4 locus accelerates wound healing in diabetes by promoting lymphangiogenesis via regulating miR-181a/Prox1 axis.
He ZY; Wei TH; Zhang PH; Zhou J; Huang XY
J Cell Physiol; 2019 Apr; 234(4):4627-4640. PubMed ID: 30565672
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
33. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
34. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
[TBL] [Abstract][Full Text] [Related]
35. NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes.
Mantelli F; Lambiase A; Colafrancesco V; Rocco ML; Macchi I; Aloe L
Eur J Ophthalmol; 2014; 24(2):247-53. PubMed ID: 24030532
[TBL] [Abstract][Full Text] [Related]
36. Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathy.
Ma J; Li C; Shao C; Gao G; Yang X
Mol Vis; 2012; 18():330-6. PubMed ID: 22355244
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody raised against human EZH2 cross-reacts with the RNA-binding protein SAFB.
Cherney RE; Mills CA; Herring LE; Braceros AK; Calabrese JM
Biol Open; 2023 Jun; 12(6):. PubMed ID: 37283223
[TBL] [Abstract][Full Text] [Related]
38. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
39. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.
Hammes HP; Lin J; Bretzel RG; Brownlee M; Breier G
Diabetes; 1998 Mar; 47(3):401-6. PubMed ID: 9519746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
